Related Experiment Video
Updated: Feb 24, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Anti-phospholipase A2 Receptor Membranous Nephropathy Presenting as Common Geriatric Complaints: A Case Report
Wai Tak Victor Li1, Kwan Hung Wu1, Oi Yee Lin2
1Department of Medicine, Queen Mary Hospital, Hong Kong, HKG.
Abstract:
Anti-phospholipase A2 receptor (anti-PLA2R) antibodies are an established cause of primary membranous nephropathy (MN). However, typical symptoms of proteinuria, such as peripheral oedema and frothy urine, are not easily identified in the elderly, and other non-specific presentations, such as hypoglycaemia and fluid overload, may lead to delays in diagnosis. We report a case of anti-PLA2R-associated MN in an elderly woman who presented with fluid overload and recurrent hypoglycaemia, both of which are common in this age group. Renal function and anti-PLA2R antibody titres improved substantially following treatment with rituximab. This case underscores the importance of early clinical suspicion and timely intervention in elderly patients in order to preserve residual renal function and optimise outcomes.
Insights
Elderly patients with anti-phospholipase A2 receptor (anti-PLA2R) antibody-associated membranous nephropathy may present with non-specific symptoms like fluid overload and hypoglycemia. Early diagnosis and rituximab treatment improved renal function and antibody levels.
Area of Science:
- Nephrology
- Immunology
Background:
- Anti-phospholipase A2 receptor (anti-PLA2R) antibodies are a key cause of primary membranous nephropathy (MN).
- Elderly patients often exhibit non-specific symptoms like fluid overload and hypoglycemia, delaying MN diagnosis.
- Typical proteinuria signs are less apparent in older individuals.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Drug Dosing: Geriatric Patients
Chronic Kidney Disease II: Clinical Manifestations
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
